Dosage Related Efficacy and Tolerability of Cannabidiol in Children With Treatment-Resistant Epileptic Encephalopathy: Preliminary Results of the CARE-E Study-Reference-Cited by-同舟云学术

Dosage Related Efficacy and Tolerability of Cannabidiol in Children With Treatment-Resistant Epileptic Encephalopathy: Preliminary Results of the CARE-E Study

Published:2019-07-03 Issue: Volume:10 Page:
ISSN:1664-2295
Container-title:Frontiers in Neurology
language:
Short-container-title:Front. Neurol.

Author:

Huntsman Richard J.,Tang-Wai Richard,Alcorn Jane,Vuong Stephanie,Acton Bryan,Corley Scott,Laprairie Robert,Lyon Andrew W.,Meier Simona,Mousseau Darrell D.,Newmeyer Doris,Prosser-Loose Erin,Seifert Blair,Tellez-Zenteno Jose,Huh Linda,Leung Edward,Major Philippe

Funder

Saskatchewan Health Research Foundation

Savoy Foundation

Publisher

Frontiers Media SA

Subject

Clinical Neurology,Neurology

Reference31 articles.

1. CBD enriched medical cannabis for intractable pediatric epilepsy: the current Israeli experience;Tzadok;Seizure.,2016

2. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial;Devinsky;Lancet Neurol,2016

3. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome;Devinsky,2017

4. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome(GWPCARE4); a randomized, double blind, placebo controlled phase 3 trial;Thiele;Lancet,2018

5. A prospective open label trial of a CBD/THC cannabis oil in Dravet syndrome;McCoy,2018

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Development of Cannabinoids as Therapeutic Agents in the United States;Pharmacological Reviews;2024-06-07

2. Les données probantes et les recommandations sur le cannabis à des fins médicales chez les enfants;Paediatrics & Child Health;2024-04-05

3. Medical cannabis for children: Evidence and recommendations;Paediatrics & Child Health;2024-04-05

4. In Vitro and In Vivo Anti-Inflammatory Potential of Cannabichromene Isolated from Hemp;Plants;2023-11-25

5. A Multi-Centre, Tolerability Study of a Cannabidiol-enriched Cannabis Herbal Extract for Chronic Headaches in Adolescents: the CAN-CHA Protocol;2023-08-07